CompoAtlas

SlimBoost Jour & Nuit

Food supplement declared in France, declaration No 2019-10-878, decision dated 25 October 2019

SlimBoost Jour & Nuit (Forté Pharma) is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.

Brand
Forté Pharma
Food business operator placing the product on the market
Laboratoire FORTE PHARMA SA
Status
Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
Form
Gélule
Daily dose
4 gélules par jour
Directions for use
2 gélules du blister JOUR le matin. 1 gélule du blister NUIT 1 et 1 gélule du blister NUIT 2 le soir
Not recommended for (according to the manufacturer)
Femmes allaitantes, Enfants (moins de 12 ans), Femmes enceintes, Sous anticoagulants

Declaration 215226, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

None of the rules we check applies to the declared ingredients.

Declared composition

Plants

PlantPartPreparationPer day
Ilex paraguariensis A. St.-Hil.FeuilleExtrait sec aqueux416 mg
Opuntia ficus-indica (L.) Mill.RaquetteExtrait sec aqueux200 mg
Curcuma longa L.RhizomeExtrait sec alcoolique63.2 mg
Vitis vinifera L.FruitExtrait sec aqueux20 mg
Cola nitida (Vent.) Schott et Endl.GraineExtrait sec aqueux10 mg

Other active ingredients

NamePer day
L-carnitinenot declared
Fructo-oligosaccharidesnot declared
Inulinenot declared
Papaïnenot declared
Bromélaïnenot declared

Micro-organisms

StrainPer day
Bifidobacterium Breve BR036,000,000,000 (unit not declared)
Lactobacillus Rhamnosus GG4,200,000,000 (unit not declared)
Lactobacillus Gasseri LGS061,800,000,000 (unit not declared)

Vitamins and minerals

Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).

Declared formNutrientEFSA limit, adults Maximum dose in France
Picolinate de chromeChromepas de limite (données insuffisantes)25 µg
NicotinamideNicotinamide (vitamine B3)900 mg54 mg
Chlorhydrate de thiamineVitamine B1 (thiamine)pas de limite (données insuffisantes)dose annulée par le Conseil d'État en 2011
RiboflavineVitamine B2 (riboflavine)pas de limite (données insuffisantes)dose annulée par le Conseil d'État en 2011
Oxyde de zincZinc25 mg15 mg

Additives

E460, E470b, E551, E172, E464, E170, E341, E141

Other ingredients

gélatine, amidon de maïs

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

Photograph the packaging

Label warnings

Contient de la caféine (16,7 mg par dose journalière pour la formule JOUR et 0,2 mg par dose journalière pour la formule NUIT 2 ), déconseillé aux femmes enceintes ou qui allaitent et aux enfants de moins de 12 ans sans avis médical. Contient du curcuma, consultez votre médecin ou votre pharmacien en cas d’usage concomitant d’anticoagulants. L’amincissement durable ne peut être obtenu que dans le cadre de mesures diététiques et d’une hygiène alimentaire contrôlée.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Curcuma longa L.
    Read the warning, when it applies and the studies cited

    TURMERIC - CURCUMA LONGA - Oral

    Route of administration: Oral (ESCOP 2003; Blumenthal et al. 2000)

    Cautions and warnings

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (ESCOP 2003; Brinker 2001; McGuffin et al. 1997).

    3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a liver or biliary disorder (HC 2025; EMA 2018; Brinker 2010; ESCOP 2003; McGuffin et al. 1997).

    5 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking medications (HC 2025).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if you experience any new symptoms including yellowing of the eyes or skin, dark urine, nausea, vomiting, stomach pain (HC 2025).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Condition of application: All uses except for Source of antioxidants and Hepatoprotectant.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Health Canada monograph dated 26 September 2025

    Turmeric -CURCUMA LONGA - Topical

    Cautions and warnings

    For external use only.

    When using this product avoid contact with eyes. If contact occurs, rinse thoroughly with water.

    Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen or last (for) more than 7 days.

    Keep out of reach of children. If swallowed, call a poison control centre or get medical help right away.

    Contraindications

    Do not use on deep or puncture wounds, animal bites or serious burns.

    Health Canada monograph dated 28 February 2025

  • L-carnitine
    Read the warning, when it applies and the studies cited

    L-CARNITINE

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (CPS 2008).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a seizure disorder (CPS 2008).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 25 July 2025

They concern the ingredient, not this product or its dose. They do not replace medical advice.

Other declarations with the same name

In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.

Brand : Forté Pharma

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

List recorded in 2019. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line